Kailera Therapeutics
PublicKailera Therapeutics is now publicly traded
The data on this page reflects Kailera Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Apr 17, 2026
Last Round
Series B
Oct 14, 2025
Total Funding Raised
$1.72B
Company Overview
Kailera Therapeutics is a biopharmaceutical company that develops a diversified pipeline of clinical-stage injectable and oral therapies for the treatment of obesity and related conditions.
Sector
Biotech
Verticals
Life Sciences, LOHAS & Wellness
AI Layer
Non-AI
Keywords
Kailera Therapeutics Comparables
Compare Kailera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Viking Therapeutics, Inc. | 92% | |
| Structure Therapeutics | 87% | |
| Pfizer | 84% |
Kailera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Apr 17, 2026 | ||||
| Series B | Oct 14, 2025 | ||||
| Series A | Oct 1, 2024 |
Key People
Founding team and executive leadership
Kailera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sirona Capital | Series B |
| Jefferies | IPO |
| Surveyor Capital | Series B |
| JP Morgan Securities | IPO |
| CPP Investments | Series B |
| Evercore ISI | IPO |
| Bain Capital Life Sciences | Series B, Series A |
Kailera Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access